Price | 1W % | 1M % | 3M % | 6M % | 1Y % | YTD % |
|---|---|---|---|---|---|---|
-- | -- | -- | -- | -- | -- | -- |
AI Generated Qualitative Analysis
Your time is precious, so save it. Use AI to get the most important information from the business.
Learn about ASP Isotopes Inc. Common Stock
ASP Isotopes Inc. Common Stock News
Feb 25, 2026 - prnewswire.com
Halper Sadeh LLC Encourages ASP Isotopes Inc. Shareholders To Contact The Firm To Discuss Their Rights
Feb 24, 2026 - prismmediawire.com
Shorepower Technologies (OTC: SPEV) Enters Merger Agreement with Aeternum Health LLC and Announces Strategic Transition to Longevity-Focused Healthcare Platform
Feb 24, 2026 - globenewswire.com
Shorepower Technologies (OTC: SPEV) Enters Merger Agreement with Aeternum Health LLC and Announces Strategic Transition to Longevity-Focused Healthcare Platform
Feb 23, 2026 - globenewswire.com
ASP Isotopes Announces Quantum Leap Energy and Necsa Advance Strategic Collaboration Aimed at Production of HALEU Nuclear Fuel
ASP Isotopes Inc. Common Stock Quantitative Score
About ASP Isotopes Inc. Common Stock
ASP Isotopes Inc., a pre-commercial stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It develops Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company also Uranium-235, an isotope of uranium for carbon-free energy industry. ASP Isotopes Inc. was incorporated in 2021 and is based in Boca Raton, Florida.
ASP Isotopes Inc. Common Stock Earnings & Revenue
What’s This Company Really Worth? Find Out Instantly.
Warren Buffett’s go-to valuation method is Discounted Cash Flow (DCF). Our tool makes it effortless — no spreadsheets, just answers in a few clicks.
ASP Isotopes Inc. Common Stock Financials
Table Compare
Compare ASPI metrics with: | |||
|---|---|---|---|
Earnings & Growth | ASPI | None | |
EPS (TTM) YoY Growth | -- | -- | |
Revenue (TTM) YoY Growth | -- | -- | |
Valuation (TTM) | ASPI | None | |
Price/Earnings Ratio | -- | -- | |
Price/Sales Ratio | -- | -- | |
Profitability & Efficiency (TTM) | ASPI | None | |
Net Profit Margin | -- | -- | |
Return on Equity | -- | -- | |
Financial Health (TTM) | ASPI | None | |
Debt/Assets Ratio | -- | -- | |
Assets/Liabilities Ratio | -- | -- | |
ASP Isotopes Inc. Common Stock Income
ASP Isotopes Inc. Common Stock Balance Sheet
ASP Isotopes Inc. Common Stock Cash Flow
ASP Isotopes Inc. Common Stock Financials Over Time
Analysts Rating
Strong Buy
Buy
Hold
Sell
Strong Sell
Metrics Scores
| Metrics | Score |
|---|---|
| Discounted Cash Flows | Sell |
| Return on Equity | Strong Sell |
| Return on Assets | Strong Sell |
| Debt/Equity Ratio | Strong Sell |
| Price/Earnings Ratio | Strong Sell |
| Price/Book Ratio | Strong Sell |
Price Targets
Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.
Historical Market Cap
Shares Outstanding
ASP Isotopes Inc. Common Stock Executives
| Name | Role |
|---|---|
| Paul Elliot Mann | Executive Chairman |
| Heather Kiessling | Chief Financial Officer |
| Robert Ainscow | Chief Operating Officer & Interim Chief Executive Officer |
| Hendrik Strydom | Chief Technology Officer |
| Gerdus Kemp | Medical Director & Chief Executive Officer of Pet Labs |
| Name | Role | Gender | Date of Birth | Pay |
|---|---|---|---|---|
| Paul Elliot Mann | Executive Chairman | Male | 1976 | 1.01M |
| Heather Kiessling | Chief Financial Officer | Female | 1965 | 600K |
| Robert Ainscow | Chief Operating Officer & Interim Chief Executive Officer | Male | 1976 | 490K |
| Hendrik Strydom | Chief Technology Officer | 1961 | 122.4K | |
| Gerdus Kemp | Medical Director & Chief Executive Officer of Pet Labs | -- |
ASP Isotopes Inc. Common Stock Insider Trades
| Date | 2 Mar |
| Name | Mann Paul Elliot |
| Role | Executive Chairman |
| Transaction | Acquired |
| Type | S-Sale |
| Shares | 162153 |
| Date | 18 Dec |
| Name | Kiessling Heather |
| Role | Chief Financial Officer |
| Transaction | Disposed |
| Type | S-Sale |
| Shares | 80000 |
| Date | 18 Dec |
| Name | Wider Todd |
| Role | Director |
| Transaction | Acquired |
| Type | A-Award |
| Shares | 36548 |
| Date | 18 Dec |
| Name | Ryan Robert John Andrew |
| Role | Director |
| Transaction | Acquired |
| Type | A-Award |
| Shares | 36548 |
| Date | 18 Dec |
| Name | Hunter Ralph L. JR |
| Role | Director |
| Transaction | Acquired |
| Type | A-Award |
| Shares | 36548 |
| Date | Name | Role | Transaction | Type | Shares |
|---|---|---|---|---|---|
| 2 Mar | Mann Paul Elliot | Executive Chairman | Acquired | S-Sale | 162153 |
| 18 Dec | Kiessling Heather | Chief Financial Officer | Disposed | S-Sale | 80000 |
| 18 Dec | Wider Todd | Director | Acquired | A-Award | 36548 |
| 18 Dec | Ryan Robert John Andrew | Director | Acquired | A-Award | 36548 |
| 18 Dec | Hunter Ralph L. JR | Director | Acquired | A-Award | 36548 |